Yang Chen Biography and Net Worth

Director of 111

Mr. Yang Chen currently serves as the Company's Senior Finance Executive. Before joining us, Mr. Chen served as Chief Financial Officer of iKang Healthcare Group Inc. (NASDAQ: KANG) from April 2013 to February 2019. Prior to that, Mr. Chen was Vice President of Finance and Strategy at Campbell Soup Asia Limited and Lee Kum Kee Sauce Group. He also held various senior finance positions at Dumex China, PepsiCo Greater China Region and Wyeth China. Previously, Mr. Chen was an auditor at Arthur Andersen & Co. He received his bachelor’s degree from Shanghai University of Finance and Economics and his EMBA degree from Olin School of Business at Washington University.

What is Yang Luke Chen's net worth?: The estimated net worth of Yang Luke Chen is at least $1.52 million as of September 28th, 2026. Mr. Chen owns 413,342 shares of 111 stock worth more than $1,516,965 as of September 29th. This net worth estimate does not reflect any other assets that Mr. Chen may own. Learn More about Yang Luke Chen's net worth.
How do I contact Yang Luke Chen?: The corporate mailing address for Mr. Chen and other 111 executives is 3-5/F NO.295 ZUCHONGZHI ROAD PUDONG NEW AREA, SHANGHAI F4, 201203. 111 can also be reached via phone at 862120536666 and via email at [email protected]. Learn More on Yang Luke Chen's contact information.
Has Yang Luke Chen been buying or selling shares of 111?: During the last ninety days, Yang Luke Chen has sold $14,781.60 of 111 stock. Most recently, Yang Luke Chen sold 38,120 shares of the business's stock in a transaction on Monday, September 28th. The shares were sold at an average price of $0.18, for a transaction totalling $6,861.60. Following the completion of the sale, the director now directly owns 413,342 shares of the company's stock, valued at $74,401.56. Learn More on Yang Luke Chen's trading history.
Are insiders buying or selling shares of 111?: In the last twelve months, insiders at the sold shares 14 times. They sold a total of 677,660 shares worth more than $155,887.00. The most recent insider tranaction occured on September, 28th when Director Yang Luke Chen sold 38,120 shares worth more than $6,861.60. Insiders at 111 own 43.9% of the company. Learn More about insider trades at 111.
Information on this page was last updated on 9/28/2026.

Yang Luke Chen Insider Trading History at 111

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/28/2026	Sell	38,120	$0.18	$6,861.60	413,342
9/23/2026	Sell	44,000	$0.18	$7,920.00	451,462
6/15/2026	Sell	44,000	$0.23	$10,120.00	495,462
6/12/2026	Sell	49,920	$0.23	$11,481.60	539,462
5/27/2026	Sell	3,400	$0.25	$850.00	589,382
5/26/2026	Sell	1,440	$0.27	$388.80	592,782

Yang Luke Chen Buying and Selling Activity at 111

111 Company Overview

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

Today's Range

Now: $3.67

$3.50

$3.52

50 Day Range

MA: $3.60

$3.13

$3.91

2 Week Range

Now: $3.67

$2.48

$11.17

Volume

1,308 shs

Average Volume

27,461 shs

Market Capitalization

$32.26 million

P/E Ratio

N/A

Dividend Yield